// App-Quantinova.ai

: Somatostatin Receptor II Antagonism Improves Glucagon Counterregulatory Responses to Recurrent Hypoglycemia in Male Sprague-Dawley Rats

Researchers

Presenter

  • MICHAEL RIDDELL

Principal Investigators

  • MAHSA JAHANGIRIESMAILI

  • ERIN R. MANDEL

  • CAYLEE A. GREENBERG

  • AOIBHE M. PASIEKA

  • TREVOR TEICH

  • OWEN CHAN

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • C-peptide

  • Somatostatin

  • Somatostatin receptor 2A

Drug/Treatment

  • Somatostatin

  • Humulin-R

  • Insulin human

  • Intranasal glucagon

  • Humulin

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved